Chatbot Intervention for Anxiety and Depressive Symptoms in Young Adults

Sponsor
University of Social Sciences and Humanities, Warsaw (Other)
Overall Status
Completed
CT.gov ID
NCT05762939
Collaborator
Ministry of Science and Higher Education, Poland (Other)
81
1
2
3
27.1

Study Details

Study Description

Brief Summary

This clinical trial compares the effects of using an artificial intelligence based therapy chatbot and a self-help book to lower anxiety and depressive symptoms. The therapy chatbot (named Fido) is an application delivering support for mental health via a conversation-like interface in a highly inflected language (Polish).

The team will recruit young people (aged 18-35) who currently struggle with anxiety and/or depression. The participants will use the chatbot or self-help materials for two weeks. Then, the researchers will check if using the chatbot or the book improved several aspects of mental health and the quality of life. Moreover, they will compare the groups for any differences in outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Chatbot
  • Behavioral: Control (book)
N/A

Detailed Description

The primary objective of this randomized controlled trial is to evaluate the effectiveness of a chatbot-delivered cognitive-behavioural intervention on anxiety and depressive symptoms (and their correlates, such as quality of life or feelings of loneliness) in a subclinical sample of about 80 participants.

The intervention results are compared to an active control intervention with popular self-help materials. Secondary objectives include the assessment and analysis of the human-chatbot therapeutic bond and general user experience.

The study uses a 2 x 3 mixed factorial design with two intervention arms (Fido chatbot vs self-help book) and three time points (T1: just prior to the intervention, T2: immediately after the intervention, T3: at a follow-up one month after the previous measurement). The primary intervention lasts two weeks.

All primary and secondary outcomes are assessed using self-administered online questionnaires in Polish. Each primary outcome measure is analyzed using a 2 (arms) x 2 (time points) ANOVA models with T1-T2 comparisons to test for the intervention effect and T1-T3 comparisons to check the stability of the intervention effect. Additional analyzes utilize standard NHST calculations and procedures (such as t-tests and correlation coefficients) alongside the conventional ⍺=.05 level.

Similarly to the previous research in this area, no blinding is used. Participants are informed about different conditions, but the research hypotheses are masked.

Study Design

Study Type:
Interventional
Actual Enrollment :
81 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: A Randomized Controlled Trial
Actual Study Start Date :
May 3, 2022
Actual Primary Completion Date :
Aug 2, 2022
Actual Study Completion Date :
Aug 2, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chatbot

Intervention using a pre-release version of Fido (https://fido.aid.pl), Polish AI-based therapy chatbot.

Behavioral: Chatbot
Participants in this condition were asked to use Fido, a Polish therapy chatbot, for two weeks. No minimal requirements of usage time were enforced, but participants had to fill in five engagement check surveys during the intervention period. Each survey had to be completed in less than 24 hours.

Active Comparator: Control (book)

Intervention using self-help materials - chapters from a popular book on cognitive therapy, including worksheets.

Behavioral: Control (book)
Participants in this condition were told to read selected chapters from a self-help book during the two-week intervention period. No minimal requirements of usage time were enforced, but participants had to fill in five engagement check surveys during the intervention period. Each survey had to be completed in less than 24 hours.

Outcome Measures

Primary Outcome Measures

  1. CESD-R Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum score of the Polish version of the Center for Epidemiologic Studies Depression Scale Revised.

  2. PHQ-9 Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum score of the Polish version of the Patient Health Questionnaire-9.

  3. PSWQ Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum score of the Polish version of the Penn State Worry Questionnaire.

  4. SWLS Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum score of the Polish version of the Satisfaction With Life Scale.

  5. PANAS Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum scores of the Polish version of the Positive and Negative Affect Scale in two subscales (Positive and Negative Affect, separately).

  6. STAI Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum score of the Polish version of the State-Trait Anxiety Inventory.

  7. R-UCLA Score Change [Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).]

    The total sum score of the Polish version of the Revised UCLA Loneliness Scale.

Other Outcome Measures

  1. ACC Score [Time point 2: Immediately after two weeks of the intervention.]

    The total sum score of the Polish version of the Acceptability E-scale. Used exclusively in the chatbot arm.

  2. HCI Scores [Time point 2: Immediately after two weeks of the intervention.]

    The total sum scores of six subscales from the Human-Computer Interaction Scale. Used exclusively in the chatbot arm.

  3. LP Score [Time point 2: Immediately after two weeks of the intervention.]

    Individual item scores from Language Pragmaticality Scale. Used exclusively in the chatbot arm.

  4. WAI-SR Score [Time point 2: Immediately after two weeks of the intervention.]

    The total sum score of the Polish version of the Working Alliance Inventory Short Revised. The Polish translation of this measure was developed by the research team. Used exclusively in the chatbot arm.

  5. Psychoeducation Test Score [Time point 2: Immediately after two weeks of the intervention.]

    The total sum score of the 12-item test which assessed the participants' acquired knowledge of psychoeducation topics.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • declaring at least mild depressive or anxiety symptoms by achieving a total score of at least 16 points on Center for Epidemiologic Studies Depression Scale Revised or at least 50 points on Penn State Worry Questionnaire

  • being able to visit the study site in Poznań (Poland) to complete all measurements

Exclusion Criteria:
  • undergoing psychotherapy, coaching or psychopharmacological treatment

  • being diagnosed with a neurological disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratory of Affective Neuroscience in Poznań, SWPS University of Social Sciences and Humanities Poznań Greater Poland Poland 61-719

Sponsors and Collaborators

  • University of Social Sciences and Humanities, Warsaw
  • Ministry of Science and Higher Education, Poland

Investigators

  • Principal Investigator: Jarosław Michałowski, PhD, SWPS University of Social Sciences and Humanities, Warsaw, Poland

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
University of Social Sciences and Humanities, Warsaw
ClinicalTrials.gov Identifier:
NCT05762939
Other Study ID Numbers:
  • RID_FIDO_RCT_1
First Posted:
Mar 10, 2023
Last Update Posted:
Mar 10, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Social Sciences and Humanities, Warsaw
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2023